ClinicalTrials.Veeva

Menu

Monocytosis and Culprit Vessel in STEMI Patients

Northwell Health logo

Northwell Health

Status

Completed

Conditions

STEMI

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Increased white blood cell count at the onset of an acute ST elevation myocardial infarction has been shown to be associated of increased incidence of heart failure and mortality. Now monocytes which are a subset of white blood cells may have a prognostic value for patients presenting with acute ST segment elevation myocardial infarction. A monocyte count of greater than 800/mm3 following acute myocardial infarction has been shown to be associated with increased incidence of left ventricular dysfunction. The investigators study would retrospectively collect data on patients with ST elevation myocardial infarction, looking for an association between high monocyte count and the culprit vessel causing the myocardial infarction. The investigators would also investigate whether monocytosis would be a marker of poor prognosis.

Enrollment

226 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • STEMI

Exclusion criteria

  • Patients on antibiotics and steroids

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems